House
DrugsGuidelinesCalculatorsPricingBlog
Log inAsk House ↗
Drugs↗Guidelines↗Calculators↗Pricing↗Blog↗Log in↗
House
Clinical AIDrug referenceRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyLog in ↗
Clinical intelligence, for physicians.© 2026 House
House
Clinical AIDrug referenceRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyLog in ↗
Clinical intelligence, for physicians.© 2026 House
Back to guidelines
Gastroenterology / ICMR

Acute liver failure

A
Source
AASLD Practice Guidance: Management of Acute Liver Failure (2023)ICMR Standard Treatment Workflow — Liver Failure (2023)
Verified Apr 2026
Ask House about this guideline

Red Flags

  • INR ≥1.5 + any-grade hepatic encephalopathy in a patient without pre-existing liver disease and illness <26 weeks — acute liver failure; transplant centre referral[1]
  • Grade III–IV encephalopathy — ICU; intracranial hypertension risk; head-up positioning, mannitol or hypertonic saline if cerebral oedema[1]
  • Paracetamol overdose with shock or rising ALT despite NAC — King's College criteria for transplant: pH <7.3 OR all of (PT >100s, creatinine >300, encephalopathy ≥III)[1]
  • Pregnancy with ALF — exclude HELLP, AFLP, HEV (high mortality in pregnancy); urgent obstetric and hepatology coordination[1]

First-line treatment

Interventions

  • Liver transplantation evaluation[1]
    All ALF patients should be discussed urgently with transplant centre; King's College criteria (paracetamol and non-paracetamol) and Clichy criteria guide listing
  • Specific aetiology-targeted therapy[1]
    Paracetamol → NAC. HBV → tenofovir/entecavir. HSV → aciclovir. Autoimmune → corticosteroids (with caution). Wilson → chelation + transplant. Mushroom (Amanita) → silibinin + NAC + supportive

First-line drug therapy

DrugClassAdultPaediatricNotes
N-acetylcysteine (NAC)[1]Glutathione precursor150 mg/kg IV over 1 h, then 50 mg/kg over 4 h, then 100 mg/kg over 16 h (21-h regimen, may extend)Same per kgParacetamol-induced ALF (definitive). Also used in non-paracetamol ALF (improves transplant-free survival per Lee 2009)
Lactulose plus rifaximin (ACLF encephalopathy)Ammonia-lowering combinationFor ACLF: lactulose 20–30 mL every 6 hours, titrated to 3–4 stools/day; rifaximin 400 mg three times daily. [2]Per weightListed in the July 2020 ICMR STW for ACLF-associated encephalopathy; the same box does not establish this regimen for ALF. [2]
Hypertonic saline or mannitol (cerebral oedema)[1]Osmotherapy3% saline to target Na 145–155 mmol/L; mannitol 0.5–1 g/kg IV bolus—Grade III–IV encephalopathy with cerebral oedema; consider ICP monitoring in selected cases
Glucose infusion (hypoglycaemia prevention)[1]IV dextrose10% dextrose infusion to maintain glucose >70 mg/dL; serial glucose monitoring—Hypoglycaemia common in ALF due to depleted hepatic gluconeogenesis
Vitamin K[1]Coagulation factor cofactor10 mg IV daily × 3 days—Correct any vitamin K deficiency contributing to coagulopathy; does NOT correct synthetic dysfunction in ALF
N-acetylcysteine (NAC)[1]
Glutathione precursor
Adult
150 mg/kg IV over 1 h, then 50 mg/kg over 4 h, then 100 mg/kg over 16 h (21-h regimen, may extend)
Paediatric
Same per kg
Paracetamol-induced ALF (definitive). Also used in non-paracetamol ALF (improves transplant-free survival per Lee 2009)
Lactulose plus rifaximin (ACLF encephalopathy)
Ammonia-lowering combination
Adult
For ACLF: lactulose 20–30 mL every 6 hours, titrated to 3–4 stools/day; rifaximin 400 mg three times daily. [2]
Paediatric
Per weight
Listed in the July 2020 ICMR STW for ACLF-associated encephalopathy; the same box does not establish this regimen for ALF. [2]
Hypertonic saline or mannitol (cerebral oedema)[1]
Osmotherapy
Adult
3% saline to target Na 145–155 mmol/L; mannitol 0.5–1 g/kg IV bolus
Paediatric
—
Grade III–IV encephalopathy with cerebral oedema; consider ICP monitoring in selected cases
Glucose infusion (hypoglycaemia prevention)[1]
IV dextrose
Adult
10% dextrose infusion to maintain glucose >70 mg/dL; serial glucose monitoring
Paediatric
—
Hypoglycaemia common in ALF due to depleted hepatic gluconeogenesis
Vitamin K[1]
Coagulation factor cofactor
Adult
10 mg IV daily × 3 days
Paediatric
—
Correct any vitamin K deficiency contributing to coagulopathy; does NOT correct synthetic dysfunction in ALF

Safety-net

  1. Avoid all hepatotoxic medications and supplements; consult clinician before any new drug or herbal product[1]
  2. Worsening confusion, drowsiness, easy bruising, vomiting blood, or yellow eyes — call emergency services immediately[1]
  3. If you survive ALF and recover, avoid alcohol completely until cleared by hepatology[1]

Referral criteria

  • Suspected ALF (INR ≥1.5 + encephalopathy without prior liver disease)Transplant centre / liver intensive care same-day[1]
  • Paracetamol overdose meeting King's College criteriaLiver transplant centre[1]
  • Pregnancy with ALFJoint hepatology + maternal-fetal medicine[1]
  • Wilson's disease ALFTransplant centre — Wilson ALF rarely recovers without transplant[1]

Clinical summary

Recognition and management of acute liver failure — coagulopathy + encephalopathy in patients without prior liver disease; transplant evaluation is time-critical.

References

  1. 1.AASLD Practice Guidance: Management of Acute Liver Failure (2023); ICMR Standard Treatment Workflow — Liver Failure (2023)
  2. 2.Standard Treatment Workflow: Liver Failure (July 2020). ICMR (2020)

On this page

  • Red flags
  • First-line treatment
  • Safety-net
  • Referral
  • References
House
Clinical AIDrug referenceRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyLog in ↗
Clinical intelligence, for physicians.© 2026 House